Table 2.
Patient | PTVresid D95 (Gy) | PTVresid Dmin (Gy) | PTVresid Dmean (Gy) | PTVgone D95 (Gy) | Lung Dmean (Gy) | Lung NTCP | Cord Dmax (Gy) | |
---|---|---|---|---|---|---|---|---|
1 | Clinical | 61.5 | 53.2 | 62.7 | 60.6 | 19.3 | 0.23 | 43.0 |
GTV boost | 63.0 | 50.1 | 70.0 | 61.0 | 19.5 | 0.25 | 44.1 | |
Replan | 63.9 | 56.3 | 66.6 | 61.1 | 19.7 | 0.25 | 42.8 | |
RPTP | 64.1 | 54.9 | 72.6 | 59.3 | 19.8 | 0.25 | 44.0 | |
2 | Clinical | 61.0 | 56.4 | 62.3 | 60.8 | 19.5 | 0.23 | 45.8 |
GTV boost | 63.6 | 59.1 | 69.6 | 62.0 | 19.7 | 0.25 | 46.0 | |
Replan | 65.3 | 59.6 | 67.3 | 62.2 | 19.5 | 0.24 | 45.1 | |
RPTP | 66.7 | 60.3 | 72.9 | 59.4 | 19.7 | 0.25 | 45.8 | |
3 | Clinical | 70.3 | 69.4 | 71.4 | 70.3 | 18.3 | 0.15 | 41.9 |
GTV boost | 76.0 | 70.9 | 83.0 | 75.5 | 18.1 | 0.15 | 42.6 | |
Replan | 79.7 | 73.2 | 81.1 | 75.1 | 18.2 | 0.15 | 40.6 | |
RPTP | 81.6 | 74.8 | 89.7 | 74.5 | 18.0 | 0.15 | 42.3 | |
4 | Clinical | 57.0 | 55.9 | 57.9 | 56.0 | 20.3 | 0.23 | 38.3 |
GTV boost | 59.1 | 56.5 | 61.9 | 56.6 | 20.3 | 0.24 | 37.6 | |
Replan | 60.8 | 59.6 | 61.8 | 56.5 | 20.3 | 0.24 | 37.7 | |
RPTP | 63.3 | 57.5 | 65.4 | 56.1 | 20.3 | 0.24 | 37.7 | |
5 | Clinical | 61.5 | 56.6 | 62.6 | 60.7 | 17.7 | 0.12 | 46.7 |
GTV boost | 63.5 | 58.5 | 67.3 | 60.6 | 18.0 | 0.14 | 42.8 | |
Replan | 63.7 | 54.8 | 65.7 | 60.8 | 17.7 | 0.13 | 41.0 | |
RPTP | 66.4 | 58.2 | 70.6 | 59.3 | 18.0 | 0.14 | 42.4 | |
Averaged difference | +6.2 | +2.8 | +10.8 | 0 | +0.2 | +0.01 | −0.7 | |
RPTP vs clinical | ||||||||
RPTP vs GTV boost | +3.4 | +2.1 | +3.9 | −1.4 | 0 | 0 | −0.1 | |
RPTP vs replan | +1.8 | +0.4 | +5.7 | −1.3 | +0.1 | 0 | +1.0 |
Abbreviations: GTV = gross tumor volume; NTCP = normal tissue complication probability; PTV = planning target volume; RPTP = robust predictive treatment planning.
The average differences between planning methods are shown in bold.